Increasing Barrier Method Use Among Oral Contraceptive Users at Risk of STDs
- 1 March 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 25 (3) , 139-143
- https://doi.org/10.1097/00007435-199803000-00006
Abstract
We evaluated whether offering a choice of barrier methods can increase overall barrier method use without decreasing condom use in women using oral contraceptives (OCs) for contraception. We randomized 167 OC users at risk for sexually transmitted diseases (STDs) into two groups, one receiving male latex condoms only (Condom group), the other receiving both male latex condoms and nonoxynol-9 film (Choice group). All participants received similar hierarchical STD protection counseling. We assessed method use with daily diaries. The Choice group protected a significantly higher percentage of their coital acts with a barrier method (month 1 to 2: 29% vs. 22%; month 3 to 4: 33% vs. 21%; and month 5 to 6: 35% vs. 19%; adjusted P = 0.012). Condom use in the Choice group was higher as well (adjusted P = 0.036). When we used a transitional multilogistic regression approach to account for differential loss to follow-up in the two groups, results were similar. Offering a choice of barrier methods increased overall barrier method use without decreasing condom use.Keywords
This publication has 9 references indexed in Scilit:
- A Risk-Assessment Tool for Integrated Reproductive Health ServicesInternational Family Planning Perspectives, 1997
- Use of Spermicide and Impact of Prophylactic Condom Use Among Sex Workers in Santa Fe de Bogota, ColombiaSexually Transmitted Diseases, 1996
- Testing for baseline balance in clinical trialsStatistics in Medicine, 1994
- From the Surgeon General, US Public Health ServicePublished by American Medical Association (AMA) ,1993
- Prevalence of AIDS-Related Risk Factors and Condom Use in the United StatesScience, 1992
- Commentary: the quest for women's prophylactic methods--hopes vs science.American Journal of Public Health, 1992
- The double bind in science policy and the protection of women from HIV infection.American Journal of Public Health, 1992
- Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infectionsThe Lancet, 1992
- A Clinical Trial of Nonoxynol-9 for Preventing Gonococcal and Chlamydial InfectionsThe Journal of Infectious Diseases, 1988